Correspondence on Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'

ANNALS OF THE RHEUMATIC DISEASES

BMJ PUBLISHING GROUP

1. Schreiber Foundation
2. German Research Council [CRC1181, FOR2886]